3D Printing of Ultra-fideLity tissues using Space for anti-ageing solutions on Earth

The project aims to develop a novel bioprinting technology in microgravity to create advanced cardiac models for studying ageing and drug efficacy, enhancing biofabrication and space research.

Subsidie
€ 4.597.578
2023

Projectdetails

Introduction

Bioprinting in Space is one of the novel promising and perspective research directions in the rapidly emerging field of biofabrication. There are several advantages of bioprinting in Space.

Advantages of Bioprinting in Space

  1. Microgravity Conditions: Under the conditions of microgravity, it is possible to bioprint constructs employing more fluidic channels and, thus, more biocompatible bio-inks.

  2. Complex Geometries: Microgravity conditions enable 3D bioprinting of tissue and organ constructs of more complex geometries with voids, cavities, and tunnels.

  3. Innovative Technology: A novel scaffold-free, label-free, and nozzle-free technology based on multi-levitation principles can be implemented under the condition of microgravity.

Ideal Space Bioprinters

The ideal Space bioprinters must be:

  • Safe
  • Automated
  • Compact
  • User-friendly

Thus, there are no doubts that systematic exploration of 3D bioprinting in Space will advance biofabrication and bioprinting technology per se.

Applications of 3D Bioprinted Tissues

Vice versa, 3D bioprinted tissues could be used to study pathophysiological biological phenomena when exposed to microgravity and cosmic radiation. This research will be useful on Earth to understand the aging conditioning of tissues and in space for the crew of deep space manned missions.

Project Goals

In PULSE, we aim at developing a radical new bioprinting technology based on multiple levitation principles and to use Space as an accelerator of aging on Earth.

Proof of Concept Study

As a proof of concept study, we will use this newly developed bioprinting technology to create cardiac 3D in vitro models able to better mimic cardiac physiology compared to organoids. We will use such models to study cardiac aging and test the efficacy of anti-inflammatory/anti-oxidative drugs with anti-aging potential.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 4.597.578
Totale projectbegroting€ 4.597.578

Tijdlijn

Startdatum1-4-2023
Einddatum31-3-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UNIVERSITEIT MAASTRICHTpenvoerder
  • OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG
  • STUDIECENTRUM VOOR KERNENERGIE / CENTRE D'ETUDE DE L'ENERGIE NUCLEAIRE
  • SPACE APPLICATIONS SERVICES NV
  • IN SRL IMPRESA SOCIALE
  • MEDIZINISCHE UNIVERSITAT GRAZ
  • RD INNOVATION APS
  • METATISSUE - BIOSOLUTIONS, LDA

Land(en)

NetherlandsGermanyBelgiumItalyAustriaDenmarkPortugal

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

€ 2.999.625
EIC Pathfinder

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

€ 2.805.403
EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

€ 4.475.946
EIC Pathfinder

building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans

THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.

€ 3.994.150

Vergelijkbare projecten uit andere regelingen

ERC Proof of...

A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow

The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.

€ 150.000
ERC Starting...

Surgical optogenetic bioprinting of engineered cardiac muscle

LIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart.

€ 1.499.705
ERC Starting...

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

€ 1.499.906
ERC Advanced...

Laser biofabrication of 3D multicellular tissue with perfusible vascular network

This project aims to revolutionize organ regeneration by developing a 3D vascular system using advanced bioprinting techniques to enable effective perfusion in tissue constructs.

€ 2.499.539
ERC Proof of...

Bioactive reinforcing bioink for hybrid bioprinting of implantable bone

The project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications.

€ 150.000